SOLID TUMOURS:@0.084848:0.038601:0.266058:0.038601:0.266058:0.019343:0.084848:0.019343:0.011712:0.020438:0.010866:0.005315:0.017498:0.006515:0.010019:0.015405:0.021613:0.020438:0.015405:0.014276:0.011712
70:@0.023705:0.038809:0.044778:0.038809:0.044778:0.019212:0.023705:0.019212:0.010536:0.010536
HANDBOOK OF ONCOLOGY:@0.084848:0.970015:0.320957:0.970015:0.320957:0.956010:0.084848:0.956010:0.011682:0.012657:0.012657:0.012726:0.009818:0.014864:0.014864:0.010109:0.004738:0.014864:0.008296:0.004738:0.014864:0.012657:0.013906:0.014864:0.007902:0.014864:0.014915:0.010126
estimated 1 600 new cases are diagnosed :@0.084242:0.096166:0.480488:0.096166:0.480488:0.080410:0.084242:0.080410:0.012508:0.007466:0.006523:0.003848:0.018049:0.013143:0.006523:0.012508:0.013181:0.004876:0.010660:0.004878:0.010660:0.010660:0.010672:0.004876:0.011738:0.012508:0.015990:0.004870:0.012450:0.013143:0.007466:0.012508:0.007466:0.004888:0.013143:0.005715:0.012508:0.004874:0.013181:0.003848:0.013143:0.012950:0.011738:0.012604:0.007466:0.012508:0.013181:0.005330
in South Africa each year.:@0.084242:0.112464:0.324295:0.112464:0.324295:0.096708:0.084242:0.096708:0.003848:0.011738:0.005330:0.009583:0.012604:0.011699:0.006523:0.011738:0.005330:0.014239:0.006042:0.005792:0.003848:0.012450:0.013143:0.005330:0.012508:0.013143:0.012450:0.011738:0.005330:0.010314:0.012508:0.013143:0.004353:0.005330
RISK FACTORS:@0.084242:0.145387:0.226209:0.145387:0.226209:0.127571:0.084242:0.127571:0.012401:0.005987:0.011118:0.013256:0.005987:0.010263:0.015822:0.016677:0.008980:0.017960:0.012401:0.011118
Exposure to tobacco remains the biggest :@0.084242:0.162832:0.480486:0.162832:0.480486:0.147076:0.084242:0.147076:0.010314:0.009236:0.013123:0.012604:0.007466:0.011699:0.005715:0.012508:0.006725:0.006523:0.012604:0.006721:0.006523:0.012604:0.013123:0.013143:0.012450:0.012450:0.012604:0.006719:0.005713:0.012508:0.018049:0.013143:0.003848:0.011738:0.007466:0.006735:0.006523:0.011738:0.012508:0.006721:0.013123:0.003848:0.012950:0.012950:0.012508:0.007466:0.006523:0.005330
risk factor. Smoking is associated with over :@0.084242:0.179131:0.480505:0.179131:0.480505:0.163375:0.084242:0.163375:0.005792:0.003848:0.007466:0.009660:0.005330:0.006042:0.013143:0.012450:0.006523:0.012604:0.004376:0.005330:0.005319:0.009583:0.018049:0.012604:0.009660:0.003848:0.011738:0.012950:0.005319:0.003848:0.007466:0.005330:0.013143:0.007466:0.007466:0.012604:0.012450:0.003848:0.013143:0.006523:0.012508:0.013181:0.005330:0.015990:0.003848:0.006523:0.011738:0.005330:0.012604:0.010660:0.012508:0.005792:0.005330
half of bladder cancer cases in men and :@0.084242:0.195429:0.480482:0.195429:0.480482:0.179673:0.084242:0.179673:0.011738:0.013143:0.003848:0.006042:0.006523:0.012604:0.006042:0.006523:0.013123:0.003848:0.013143:0.013181:0.013181:0.012508:0.005792:0.006523:0.012450:0.013143:0.011738:0.012450:0.012508:0.005792:0.006523:0.012450:0.013143:0.007466:0.012508:0.007466:0.006523:0.003848:0.011738:0.006523:0.018049:0.012508:0.011738:0.006523:0.013143:0.011738:0.013181:0.005330
one-third  of  cases among  women.  Men :@0.084242:0.211727:0.480494:0.211727:0.480494:0.195971:0.084242:0.195971:0.012604:0.011738:0.012508:0.006388:0.006523:0.011738:0.003848:0.005665:0.013181:0.005330:0.004356:0.012604:0.006042:0.005330:0.004351:0.012450:0.013143:0.007466:0.012508:0.007466:0.009698:0.013143:0.018049:0.012604:0.011738:0.012950:0.005330:0.004349:0.015990:0.012604:0.018049:0.012508:0.011738:0.005330:0.005330:0.004343:0.017684:0.012508:0.011738:0.005330
are three times more likely  to develop :@0.084242:0.228026:0.480482:0.228026:0.480482:0.212270:0.084242:0.212270:0.013143:0.005715:0.012508:0.011950:0.006523:0.011738:0.005707:0.012508:0.012508:0.011950:0.006523:0.003848:0.018049:0.012508:0.007466:0.011950:0.018049:0.012604:0.005709:0.012508:0.011950:0.003848:0.003848:0.009660:0.012508:0.003848:0.010314:0.005330:0.006633:0.006523:0.012604:0.011950:0.013181:0.012508:0.010660:0.012508:0.003848:0.012604:0.013123:0.005330
bladder cancer than women. Occupa-:@0.084242:0.244324:0.475152:0.244324:0.475152:0.228568:0.084242:0.228568:0.013123:0.003848:0.013143:0.013181:0.013181:0.012508:0.005792:0.010680:0.012450:0.013143:0.011738:0.012450:0.012508:0.005792:0.010680:0.006523:0.011738:0.013143:0.011738:0.010680:0.015990:0.012604:0.018049:0.012508:0.011738:0.005330:0.010680:0.016722:0.012450:0.012450:0.011699:0.013123:0.013143:0.006388
tional exposure  to  chemicals may also :@0.084242:0.260622:0.480492:0.260622:0.480492:0.244866:0.084242:0.244866:0.006523:0.003848:0.012604:0.011738:0.013143:0.003848:0.012238:0.012508:0.009236:0.013123:0.012604:0.007466:0.011699:0.005711:0.012508:0.005330:0.006898:0.006523:0.012604:0.005330:0.006893:0.012450:0.011738:0.012508:0.018049:0.003848:0.012450:0.013143:0.003848:0.007466:0.012238:0.018049:0.013143:0.010314:0.012238:0.013143:0.003848:0.007466:0.012604:0.005330
play a role; metalworkers, mechanics and :@0.084242:0.276921:0.480474:0.276921:0.480474:0.261165:0.084242:0.261165:0.013123:0.003848:0.013143:0.010314:0.005346:0.013143:0.005330:0.005711:0.012604:0.003848:0.012508:0.005330:0.005330:0.018049:0.012508:0.006523:0.013143:0.003848:0.015990:0.012604:0.005792:0.009660:0.012508:0.005792:0.007466:0.005330:0.005330:0.018049:0.012508:0.012450:0.011738:0.013143:0.011738:0.003848:0.012450:0.007466:0.005330:0.013143:0.011738:0.013181:0.005330
hairdressers seem to have increased risk.:@0.084242:0.293219:0.459743:0.293219:0.459743:0.277463:0.084242:0.277463:0.011738:0.013143:0.003848:0.005678:0.013181:0.005713:0.012508:0.007466:0.007466:0.012508:0.005792:0.007466:0.005330:0.007466:0.012508:0.012508:0.018049:0.005330:0.006523:0.012604:0.005330:0.011738:0.013143:0.010660:0.012508:0.005330:0.003848:0.011738:0.012450:0.005700:0.012508:0.013143:0.007466:0.012508:0.013181:0.005330:0.005792:0.003848:0.007466:0.009660:0.005330
SIGNS AND SYMPTOMS:@0.084242:0.326148:0.317717:0.326148:0.317717:0.308332:0.084242:0.308332:0.011118:0.005987:0.017960:0.015822:0.011118:0.005987:0.015822:0.015822:0.014966:0.005987:0.011118:0.013256:0.019242:0.011973:0.008980:0.017960:0.019242:0.011118
Bladder cancer characteristically  causes :@0.084242:0.343593:0.480476:0.343593:0.480476:0.327837:0.084242:0.327837:0.011045:0.003848:0.013143:0.013181:0.013181:0.012508:0.005792:0.008852:0.012450:0.013143:0.011738:0.012450:0.012508:0.005792:0.008852:0.012450:0.011738:0.013143:0.005792:0.013143:0.012450:0.006523:0.012508:0.005792:0.003848:0.007466:0.006523:0.003848:0.012450:0.013143:0.003848:0.003848:0.010314:0.005330:0.003535:0.012450:0.013143:0.011699:0.007466:0.012508:0.007466:0.005330
painless macroscopic or microscopic hae-:@0.084242:0.359892:0.475154:0.359892:0.475154:0.344136:0.084242:0.344136:0.013123:0.013143:0.003848:0.011738:0.003848:0.012508:0.007466:0.007466:0.004285:0.018049:0.013143:0.012450:0.005713:0.012604:0.007466:0.012450:0.012604:0.013123:0.003848:0.012450:0.004272:0.012604:0.005792:0.004260:0.018049:0.003848:0.012450:0.005717:0.012604:0.007466:0.012450:0.012604:0.013123:0.003848:0.012450:0.004272:0.011738:0.013143:0.012508:0.006388
maturia. Other possible symptoms include :@0.084242:0.376190:0.480482:0.376190:0.480482:0.360434:0.084242:0.360434:0.018049:0.013143:0.006523:0.011699:0.005792:0.003848:0.013143:0.005330:0.005811:0.016722:0.006523:0.011738:0.012508:0.005792:0.005800:0.013123:0.012604:0.007466:0.007466:0.003848:0.013123:0.003848:0.012508:0.005823:0.007466:0.010314:0.018049:0.013123:0.006523:0.012604:0.018049:0.007466:0.005811:0.003848:0.011738:0.012450:0.003848:0.011699:0.013181:0.012508:0.005330
dysuria or painful micturition, frequency or :@0.084242:0.392488:0.480492:0.392488:0.480492:0.376732:0.084242:0.376732:0.013181:0.010314:0.007466:0.011699:0.005792:0.003848:0.013143:0.005388:0.012604:0.005792:0.005372:0.013123:0.013143:0.003848:0.011738:0.006042:0.011699:0.003848:0.005388:0.018049:0.003848:0.012450:0.006523:0.011699:0.005792:0.003848:0.006523:0.003848:0.012604:0.011738:0.005330:0.005369:0.006042:0.005713:0.012508:0.013123:0.011699:0.012508:0.011738:0.012450:0.010314:0.005376:0.012604:0.005792:0.005330
urgency.:@0.084242:0.408787:0.167037:0.408787:0.167037:0.393031:0.084242:0.393031:0.011699:0.005805:0.012950:0.012508:0.011738:0.012450:0.010314:0.005330
DIAGNOSIS:@0.084242:0.441712:0.200980:0.441712:0.200980:0.423897:0.084242:0.423897:0.014966:0.005987:0.015822:0.017960:0.015822:0.017960:0.011118:0.005987:0.011118
The  gold standard for  diagnosing blad-:@0.084242:0.459158:0.475150:0.459158:0.475150:0.443402:0.084242:0.443402:0.008197:0.011738:0.012508:0.005330:0.005511:0.012950:0.012604:0.003848:0.013181:0.010853:0.007466:0.006523:0.013143:0.011738:0.013181:0.013143:0.005678:0.013181:0.010853:0.006042:0.012604:0.005792:0.005330:0.005511:0.013181:0.003848:0.013143:0.012950:0.011738:0.012604:0.007466:0.003848:0.011738:0.012950:0.010853:0.013123:0.003848:0.013143:0.013181:0.006388
der cancer is biopsy obtained during cys-:@0.084242:0.475456:0.475152:0.475456:0.475152:0.459700:0.084242:0.459700:0.013181:0.012508:0.005792:0.006177:0.012450:0.013143:0.011738:0.012450:0.012508:0.005792:0.006177:0.003848:0.007466:0.006177:0.013123:0.003848:0.012604:0.013123:0.007466:0.010314:0.006177:0.012604:0.013123:0.006523:0.013143:0.003848:0.011738:0.012508:0.013181:0.006177:0.013181:0.011699:0.005792:0.003848:0.011738:0.012950:0.006177:0.012450:0.010314:0.007466:0.006388
toscopy. It is also important for accurate :@0.084242:0.491754:0.480488:0.491754:0.480488:0.475998:0.084242:0.475998:0.006523:0.012604:0.007466:0.012450:0.012604:0.013123:0.010314:0.005330:0.007957:0.004349:0.006523:0.007966:0.003848:0.007466:0.007966:0.013143:0.003848:0.007466:0.012604:0.007966:0.003848:0.018049:0.013123:0.012604:0.005792:0.006523:0.013143:0.011738:0.006523:0.007955:0.006042:0.012604:0.005792:0.007955:0.013143:0.012450:0.012450:0.011699:0.005792:0.013143:0.006523:0.012508:0.005330
staging,  which determines further  man-:@0.084242:0.508053:0.475161:0.508053:0.475161:0.492297:0.084242:0.492297:0.007466:0.006523:0.013143:0.012950:0.003848:0.011738:0.012950:0.005330:0.005330:0.006454:0.015990:0.011738:0.003848:0.012450:0.011738:0.011796:0.013181:0.012508:0.006523:0.012508:0.006317:0.018049:0.003848:0.011738:0.012508:0.007466:0.011796:0.006042:0.011699:0.005792:0.006523:0.011738:0.012508:0.005792:0.005330:0.006442:0.018049:0.013143:0.011738:0.006388
agement, since the major prognostic fac-:@0.084242:0.524351:0.475161:0.524351:0.475161:0.508595:0.084242:0.508595:0.013143:0.012950:0.012508:0.018049:0.012508:0.011738:0.006523:0.005330:0.005763:0.007466:0.003848:0.011738:0.012450:0.012508:0.005773:0.006523:0.011738:0.012508:0.005773:0.018049:0.013143:0.003906:0.012604:0.005792:0.005773:0.013123:0.005715:0.012604:0.012950:0.011738:0.012604:0.007466:0.006523:0.003848:0.012450:0.005773:0.006042:0.013143:0.012450:0.006388
tors in carcinoma of the bladder are the :@0.084242:0.540649:0.480494:0.540649:0.480494:0.524893:0.084242:0.524893:0.006523:0.012604:0.005792:0.007466:0.007643:0.003848:0.011738:0.007658:0.012450:0.013143:0.005657:0.012450:0.003848:0.011738:0.012604:0.018049:0.013143:0.007658:0.012604:0.006042:0.007647:0.006523:0.011738:0.012508:0.007643:0.013123:0.003848:0.013143:0.013181:0.013181:0.012508:0.005792:0.007645:0.013143:0.005715:0.012508:0.007649:0.006523:0.011738:0.012508:0.005330
depth of invasion into the bladder wall :@0.084242:0.556948:0.480463:0.556948:0.480463:0.541192:0.084242:0.541192:0.013181:0.012508:0.013123:0.006523:0.011738:0.010506:0.012604:0.006042:0.010506:0.003848:0.011738:0.010660:0.013143:0.007466:0.003848:0.012604:0.011738:0.010506:0.003848:0.011738:0.006523:0.012604:0.010506:0.006523:0.011738:0.012508:0.010506:0.013123:0.003848:0.013143:0.013181:0.013181:0.012508:0.005792:0.010506:0.015990:0.013143:0.003848:0.003848:0.005330
and the degree of differentiation of the :@0.084242:0.573246:0.480532:0.573246:0.480532:0.557490:0.084242:0.557490:0.013143:0.011738:0.013181:0.009140:0.006523:0.011738:0.012508:0.009140:0.013181:0.012508:0.012950:0.005709:0.012508:0.012508:0.009140:0.012604:0.006042:0.009140:0.013181:0.003848:0.006104:0.006042:0.012508:0.005709:0.012508:0.011738:0.006523:0.003848:0.013143:0.006523:0.003848:0.012604:0.011738:0.009140:0.012604:0.006042:0.009140:0.006523:0.011738:0.012508:0.005330
tumour.:@0.084242:0.589544:0.154516:0.589544:0.154516:0.573788:0.084242:0.573788:0.006523:0.011699:0.018049:0.012604:0.011699:0.004368:0.005330
PATHOLOGY:@0.084242:0.622473:0.212097:0.622473:0.212097:0.604658:0.084242:0.604658:0.011973:0.015822:0.008980:0.014539:0.017960:0.009407:0.017960:0.017960:0.013256
The  most common  pathology  in bladder :@0.084242:0.639918:0.480497:0.639918:0.480497:0.624162:0.084242:0.624162:0.008197:0.011738:0.012508:0.005330:0.002890:0.018049:0.012604:0.007466:0.006523:0.008236:0.012450:0.012604:0.018049:0.018049:0.012604:0.011738:0.005330:0.002892:0.013123:0.013143:0.006523:0.011738:0.012604:0.003848:0.012604:0.012950:0.010314:0.005330:0.002892:0.003848:0.011738:0.008236:0.013123:0.003848:0.013143:0.013181:0.013181:0.012508:0.005792:0.005330
malignancy is urothelial or transitional cell :@0.084242:0.656217:0.480486:0.656217:0.480486:0.640461:0.084242:0.640461:0.018049:0.013143:0.003848:0.003848:0.012950:0.011738:0.013143:0.011738:0.012450:0.010314:0.006331:0.003848:0.007466:0.006331:0.011699:0.005713:0.012604:0.006523:0.011738:0.012508:0.003848:0.003848:0.013143:0.003848:0.006331:0.012604:0.005792:0.006317:0.006523:0.005792:0.013143:0.011738:0.007466:0.003848:0.006523:0.003848:0.012604:0.011738:0.013143:0.003848:0.006331:0.012450:0.012508:0.003848:0.003848:0.005330
carcinoma (85-90%). Other  histologies in-:@0.084242:0.672515:0.475156:0.672515:0.475156:0.656759:0.084242:0.656759:0.012450:0.013143:0.005657:0.012450:0.003848:0.011738:0.012604:0.018049:0.013143:0.008428:0.007100:0.010660:0.010660:0.006388:0.010660:0.010660:0.014913:0.007100:0.005330:0.008428:0.016722:0.006523:0.011738:0.012508:0.005792:0.005330:0.003083:0.011738:0.003848:0.007466:0.006523:0.012604:0.003848:0.012604:0.012950:0.003848:0.012508:0.007466:0.008428:0.003848:0.011738:0.006388
clude squamous carcinoma, adenocarci-:@0.084242:0.688813:0.475150:0.688813:0.475150:0.673057:0.084242:0.673057:0.012450:0.003848:0.011699:0.013181:0.012508:0.005484:0.007466:0.013123:0.011699:0.013143:0.018049:0.012604:0.011699:0.007466:0.005484:0.012450:0.013143:0.005659:0.012450:0.003848:0.011738:0.012604:0.018049:0.013143:0.005330:0.005484:0.013143:0.013181:0.012508:0.011738:0.012604:0.012450:0.013143:0.005653:0.012450:0.003848:0.006388
noma, small-cell cancer, lymphomas and :@0.084242:0.705112:0.480465:0.705112:0.480465:0.689356:0.084242:0.689356:0.011738:0.012604:0.018049:0.013143:0.005330:0.006706:0.007466:0.018049:0.013143:0.003848:0.003848:0.006388:0.012450:0.012508:0.003848:0.003848:0.006716:0.012450:0.013143:0.011738:0.012450:0.012508:0.003764:0.005330:0.006716:0.003848:0.010314:0.018049:0.013123:0.011738:0.012604:0.018049:0.013143:0.007466:0.006716:0.013143:0.011738:0.013181:0.005330
sarcomas.:@0.084242:0.721410:0.179554:0.721410:0.179554:0.705654:0.084242:0.705654:0.007466:0.013143:0.005661:0.012450:0.012604:0.018049:0.013143:0.007466:0.005330
TREATMENT:@0.084242:0.754336:0.196704:0.754336:0.196704:0.736521:0.084242:0.736521:0.008980:0.012401:0.011118:0.015822:0.008980:0.019242:0.011118:0.015822:0.008980
The management of bladder cancer can :@0.084242:0.771782:0.480488:0.771782:0.480488:0.756026:0.084242:0.756026:0.008197:0.011738:0.012508:0.005854:0.018049:0.013143:0.011738:0.013143:0.012950:0.012508:0.018049:0.012508:0.011738:0.006523:0.005857:0.012604:0.006042:0.005857:0.013123:0.003848:0.013143:0.013181:0.013181:0.012508:0.005792:0.005869:0.012450:0.013143:0.011738:0.012450:0.012508:0.005792:0.005855:0.012450:0.013143:0.011738:0.005330
be divided into three broad groups, based :@0.084242:0.788080:0.480480:0.788080:0.480480:0.772324:0.084242:0.772324:0.013123:0.012508:0.004183:0.013181:0.003848:0.010660:0.003848:0.013195:0.012508:0.013181:0.004183:0.003848:0.011738:0.006523:0.012604:0.004181:0.006523:0.011738:0.005707:0.012508:0.012508:0.004179:0.013123:0.005715:0.012604:0.013143:0.013181:0.004181:0.012950:0.005711:0.012604:0.011699:0.013123:0.007466:0.005330:0.004179:0.013123:0.013143:0.007466:0.012508:0.013181:0.005330
on the stage of the disease::@0.084242:0.804379:0.343457:0.804379:0.343457:0.788623:0.084242:0.788623:0.012604:0.011738:0.005330:0.006523:0.011738:0.012508:0.005330:0.007466:0.006523:0.013143:0.012950:0.012508:0.005330:0.012604:0.006042:0.005330:0.006523:0.011738:0.012508:0.005330:0.013181:0.003848:0.007466:0.012508:0.013143:0.007466:0.012508:0.005330
n   :@0.084242:0.817560:0.107051:0.817560:0.107051:0.809120:0.084242:0.809120:0.009762:0.003566:0.005914:0.003566
Non-muscle-invasive disease:@0.103485:0.820680:0.370185:0.820680:0.370185:0.804924:0.103485:0.804924:0.014239:0.012604:0.011738:0.006388:0.018049:0.011699:0.007466:0.012450:0.003848:0.012508:0.006388:0.003848:0.011738:0.010660:0.013143:0.007466:0.003848:0.010660:0.012508:0.005330:0.013181:0.003848:0.007466:0.012508:0.013143:0.007466:0.012508
n   :@0.084242:0.833859:0.107051:0.833859:0.107051:0.825419:0.084242:0.825419:0.009762:0.003566:0.005914:0.003566
Muscle-invasive disease:@0.103485:0.836979:0.324849:0.836979:0.324849:0.821223:0.103485:0.821223:0.017684:0.011699:0.007466:0.012450:0.003848:0.012508:0.006388:0.003848:0.011738:0.010660:0.013143:0.007466:0.003848:0.010660:0.012508:0.005330:0.013181:0.003848:0.007466:0.012508:0.013143:0.007466:0.012508
n   :@0.084242:0.850159:0.107051:0.850159:0.107051:0.841719:0.084242:0.841719:0.009762:0.003566:0.005914:0.003566
Metastatic disease.:@0.103485:0.853278:0.284075:0.853278:0.284075:0.837522:0.103485:0.837522:0.017684:0.012508:0.006523:0.013143:0.007466:0.006523:0.013143:0.006523:0.003848:0.012450:0.005330:0.013181:0.003848:0.007466:0.012508:0.013143:0.007466:0.012508:0.005330
Non-muscle-invasive disease:@0.084242:0.886200:0.389128:0.886200:0.389128:0.868179:0.084242:0.868179:0.015822:0.013683:0.012828:0.008980:0.020098:0.012828:0.009407:0.013683:0.005131:0.013683:0.008980:0.005131:0.012828:0.011973:0.014111:0.009407:0.005131:0.011973:0.013683:0.005987:0.014111:0.005131:0.009407:0.013683:0.014111:0.009407:0.013683
The  initial treatment  of  non-muscle-inva-:@0.084242:0.903645:0.475152:0.903645:0.475152:0.887889:0.084242:0.887889:0.008197:0.011738:0.012508:0.005330:0.004449:0.003848:0.011738:0.003848:0.006523:0.003848:0.013143:0.003848:0.009794:0.006523:0.005711:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.005330:0.004451:0.012604:0.006042:0.005330:0.004455:0.011738:0.012604:0.011738:0.006388:0.018040:0.011699:0.007466:0.012450:0.003848:0.012508:0.006388:0.003848:0.011738:0.010660:0.013156:0.006388
sive bladder tumours is a complete tran-:@0.084242:0.919944:0.475156:0.919944:0.475156:0.904188:0.084242:0.904188:0.007466:0.003848:0.010660:0.012508:0.008036:0.013123:0.003848:0.013143:0.013181:0.013181:0.012508:0.005792:0.008024:0.006523:0.011699:0.018049:0.012604:0.011699:0.005792:0.007466:0.008024:0.003848:0.007466:0.008036:0.013143:0.008024:0.012450:0.012604:0.018049:0.013123:0.003848:0.012508:0.006523:0.012508:0.008024:0.006523:0.005792:0.013143:0.011738:0.006388
surethral resection of the bladder tumour :@0.084242:0.936242:0.480505:0.936242:0.480505:0.920486:0.084242:0.920486:0.007466:0.011699:0.005715:0.012508:0.006523:0.011738:0.005792:0.013143:0.003848:0.007314:0.005711:0.012508:0.007466:0.012508:0.012450:0.006523:0.003848:0.012604:0.011738:0.007316:0.012604:0.006042:0.007314:0.006523:0.011738:0.012508:0.007312:0.013123:0.003848:0.013143:0.013181:0.013181:0.012508:0.005792:0.007331:0.006523:0.011699:0.018049:0.012604:0.011699:0.005792:0.005330
(TURBT), which is usually carried out at the :@0.523643:0.096164:0.919890:0.096164:0.919890:0.080408:0.523643:0.080408:0.007100:0.008197:0.012604:0.011680:0.011045:0.008197:0.007100:0.005330:0.006081:0.015990:0.011738:0.003848:0.012450:0.011738:0.006081:0.003848:0.007466:0.006092:0.011699:0.007466:0.011699:0.013143:0.003848:0.003848:0.010314:0.006096:0.012450:0.013143:0.005792:0.005792:0.003848:0.012508:0.013181:0.006081:0.012604:0.011699:0.006523:0.006081:0.013143:0.006523:0.006081:0.006523:0.011738:0.012508:0.005330
time of diagnosis. Many patients can be :@0.523643:0.112607:0.919892:0.112607:0.919892:0.096851:0.523643:0.096851:0.006523:0.003848:0.018049:0.012508:0.008178:0.012604:0.006042:0.008168:0.013181:0.003848:0.013143:0.012950:0.011738:0.012604:0.007466:0.003848:0.007466:0.005330:0.008178:0.017684:0.013143:0.011738:0.010314:0.008178:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.008178:0.012450:0.013143:0.011738:0.008178:0.013123:0.012508:0.005330
successfully managed  with a localised :@0.523643:0.129051:0.919873:0.129051:0.919873:0.113295:0.523643:0.113295:0.007466:0.011699:0.012450:0.012450:0.012508:0.007466:0.007466:0.006042:0.011699:0.003848:0.003848:0.010314:0.013701:0.018049:0.013143:0.011738:0.013143:0.012950:0.012508:0.013181:0.005330:0.008361:0.015990:0.003848:0.006523:0.011738:0.013701:0.013143:0.013701:0.003848:0.012604:0.012450:0.013143:0.003848:0.003848:0.007466:0.012508:0.013181:0.005330
resection.:@0.523643:0.145495:0.614330:0.145495:0.614330:0.129739:0.523643:0.129739:0.005713:0.012508:0.007466:0.012508:0.012450:0.006523:0.003848:0.012604:0.011738:0.005330
Additional intravesical therapy is gener-:@0.541827:0.161939:0.914552:0.161939:0.914552:0.146183:0.541827:0.146183:0.014239:0.013181:0.013181:0.003848:0.006523:0.003848:0.012604:0.011738:0.013143:0.003848:0.006312:0.003848:0.011738:0.006523:0.005792:0.013143:0.010660:0.012508:0.007466:0.003848:0.012450:0.013143:0.003848:0.006331:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.006312:0.003848:0.007466:0.006325:0.012950:0.012508:0.011738:0.012508:0.005778:0.006388
ally recommended for patients with inter-:@0.523643:0.178383:0.914564:0.178383:0.914564:0.162627:0.523643:0.162627:0.013143:0.003848:0.003848:0.010314:0.006619:0.005711:0.012508:0.012450:0.012604:0.018049:0.018049:0.012508:0.011728:0.013181:0.012508:0.013181:0.006619:0.006042:0.012604:0.005792:0.006606:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.006619:0.015990:0.003848:0.006523:0.011738:0.006619:0.003848:0.011738:0.006523:0.012508:0.005792:0.006388
mediate- to high-risk, non-muscle-invasive :@0.523643:0.194827:0.919871:0.194827:0.919871:0.179071:0.523643:0.179071:0.018049:0.012508:0.013181:0.003848:0.013143:0.006523:0.012508:0.006388:0.006042:0.006523:0.012604:0.006042:0.011738:0.003848:0.012950:0.011738:0.006388:0.005792:0.003848:0.007466:0.009660:0.005330:0.006042:0.011738:0.012604:0.011738:0.006388:0.018049:0.011688:0.007466:0.012450:0.003848:0.012508:0.006388:0.003848:0.011738:0.010660:0.013143:0.007466:0.003848:0.010660:0.012508:0.005330
bladder tumours. This option results in high :@0.523643:0.211271:0.919886:0.211271:0.919886:0.195515:0.523643:0.195515:0.013123:0.003848:0.013143:0.013181:0.013181:0.012508:0.005792:0.005705:0.006523:0.011699:0.018049:0.012604:0.011699:0.005792:0.007466:0.005330:0.005688:0.008197:0.011738:0.003848:0.007466:0.005703:0.012604:0.013123:0.006523:0.003848:0.012604:0.011738:0.005694:0.005713:0.012508:0.007466:0.011699:0.003848:0.006523:0.007466:0.005705:0.003848:0.011738:0.005703:0.011738:0.003848:0.012950:0.011738:0.005330
local concentrations of a therapeutic :@0.523643:0.227714:0.919888:0.227714:0.919888:0.211958:0.523643:0.211958:0.003848:0.012604:0.012450:0.013143:0.003848:0.015567:0.012450:0.012604:0.011738:0.012450:0.012508:0.011738:0.006510:0.005792:0.013143:0.006523:0.003848:0.012604:0.011738:0.007466:0.015567:0.012604:0.006042:0.015567:0.013143:0.015567:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.012508:0.011699:0.006523:0.003848:0.012450:0.005330
agent within the bladder, decreasing the :@0.523643:0.244158:0.919888:0.244158:0.919888:0.228402:0.523643:0.228402:0.013143:0.012950:0.012508:0.011738:0.006523:0.007043:0.015990:0.003848:0.006523:0.011738:0.003848:0.011738:0.007050:0.006523:0.011738:0.012508:0.007045:0.013123:0.003848:0.013143:0.013181:0.013181:0.012508:0.003775:0.005330:0.007048:0.013181:0.012508:0.012450:0.005711:0.012508:0.013143:0.007466:0.003848:0.011738:0.012950:0.007052:0.006523:0.011738:0.012508:0.005330
risk of recurrence and the need for  cys-:@0.523643:0.260602:0.914568:0.260602:0.914568:0.244846:0.523643:0.244846:0.005792:0.003848:0.007466:0.009660:0.008948:0.012604:0.006042:0.008948:0.005713:0.012508:0.012450:0.011699:0.005792:0.005703:0.012508:0.011738:0.012450:0.012508:0.008948:0.013143:0.011738:0.013181:0.008948:0.006523:0.011738:0.012508:0.008948:0.011738:0.012508:0.012508:0.013181:0.008948:0.006042:0.012604:0.005792:0.005330:0.003608:0.012450:0.010314:0.007466:0.006388
tectomy. Bacillus Calmette Guerin (BCG) :@0.523643:0.277046:0.919875:0.277046:0.919875:0.261290:0.523643:0.261290:0.006523:0.012508:0.012450:0.006523:0.012604:0.018049:0.010314:0.005330:0.007605:0.011045:0.013143:0.012450:0.003848:0.003848:0.003866:0.011699:0.007466:0.007620:0.015644:0.013143:0.003848:0.018049:0.012508:0.006523:0.006523:0.012508:0.007620:0.016779:0.011699:0.012508:0.005792:0.003848:0.011738:0.007610:0.007100:0.011045:0.015644:0.016779:0.007100:0.005330
is the most commonly used agent for intra-:@0.523643:0.293490:0.914571:0.293490:0.914571:0.277734:0.523643:0.277734:0.003848:0.007466:0.004426:0.006523:0.011738:0.012508:0.004426:0.018049:0.012604:0.007466:0.006523:0.004426:0.012450:0.012604:0.018049:0.018049:0.012604:0.011738:0.003848:0.010314:0.004426:0.011699:0.007466:0.012508:0.013181:0.004426:0.013143:0.012950:0.012508:0.011738:0.006523:0.004416:0.006042:0.012604:0.005792:0.004416:0.003848:0.011738:0.006523:0.005792:0.013143:0.006388
vesical immunotherapy for high-grade dis-:@0.523643:0.309934:0.914558:0.309934:0.914558:0.294178:0.523643:0.294178:0.010660:0.012508:0.007466:0.003848:0.012450:0.013143:0.003848:0.004591:0.003848:0.018049:0.018049:0.011699:0.011738:0.012604:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.004580:0.006042:0.012604:0.005792:0.004566:0.011738:0.003848:0.012950:0.011738:0.006388:0.012950:0.005792:0.013143:0.013181:0.012508:0.004568:0.013181:0.003848:0.007466:0.006388
ease (Ta, Tis, T1). Mitomycin C is the most :@0.523643:0.326377:0.919857:0.326377:0.919857:0.310622:0.523643:0.310622:0.012508:0.013143:0.007466:0.012508:0.007043:0.007100:0.007201:0.013143:0.005330:0.007043:0.008784:0.003848:0.007466:0.005330:0.007043:0.008197:0.010660:0.007100:0.005330:0.007043:0.017684:0.003848:0.006523:0.012604:0.018049:0.010314:0.012450:0.003848:0.011738:0.007043:0.015644:0.007043:0.003848:0.007466:0.007043:0.006523:0.011738:0.012508:0.007043:0.018049:0.012604:0.007466:0.006523:0.005330
commonly used chemotherapy agent :@0.523643:0.342821:0.919884:0.342821:0.919884:0.327065:0.523643:0.327065:0.012450:0.012604:0.018049:0.018049:0.012604:0.011738:0.003848:0.010314:0.016356:0.011699:0.007466:0.012508:0.013181:0.016356:0.012450:0.011738:0.012508:0.018049:0.012604:0.006523:0.011738:0.012490:0.005792:0.013143:0.013123:0.010314:0.016356:0.013143:0.012950:0.012508:0.011738:0.006523:0.005330
and is appropriate for the intravesical use :@0.523643:0.359265:0.919894:0.359265:0.919894:0.343509:0.523643:0.343509:0.013143:0.011738:0.013181:0.006177:0.003848:0.007466:0.006177:0.013143:0.013123:0.013123:0.005719:0.012604:0.013123:0.005792:0.003848:0.013143:0.006523:0.012508:0.006177:0.006042:0.012604:0.005792:0.006163:0.006523:0.011738:0.012508:0.006167:0.003848:0.011738:0.006523:0.005792:0.013143:0.010660:0.012508:0.007466:0.003848:0.012450:0.013143:0.003848:0.006188:0.011699:0.007466:0.012508:0.005330
for intermediate-risk disease.:@0.523643:0.375709:0.788030:0.375709:0.788030:0.359953:0.523643:0.359953:0.006042:0.012604:0.005792:0.005330:0.003848:0.011738:0.006523:0.012508:0.006308:0.018049:0.012508:0.013181:0.003848:0.013143:0.006523:0.012508:0.006388:0.005792:0.003848:0.007466:0.009660:0.005330:0.013181:0.003848:0.007466:0.012508:0.013143:0.007466:0.012508:0.005330
Following initial treatment,  careful sur-:@0.541827:0.392153:0.914552:0.392153:0.914552:0.376397:0.541827:0.376397:0.009333:0.012604:0.003848:0.003848:0.012604:0.015990:0.003848:0.011738:0.012950:0.010968:0.003848:0.011738:0.003848:0.006523:0.003848:0.013143:0.003848:0.010968:0.006523:0.005709:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.005330:0.005330:0.005625:0.012450:0.013143:0.005715:0.012508:0.006042:0.011699:0.003848:0.010968:0.007466:0.011699:0.005792:0.006388
veillance for  secondary  tumours  of  the :@0.523643:0.408597:0.919884:0.408597:0.919884:0.392841:0.523643:0.392841:0.010660:0.012508:0.003848:0.003848:0.003848:0.013143:0.011738:0.012450:0.012508:0.011911:0.006042:0.012604:0.005792:0.005330:0.006562:0.007466:0.012508:0.012450:0.012604:0.011738:0.013181:0.013143:0.005792:0.010314:0.005330:0.006562:0.006523:0.011699:0.018049:0.012604:0.011699:0.005792:0.007466:0.005330:0.006560:0.012604:0.006042:0.005330:0.006566:0.006523:0.011738:0.012508:0.005330
urinary tract is required for both low- and :@0.523643:0.425041:0.919888:0.425041:0.919888:0.409285:0.523643:0.409285:0.011699:0.005792:0.003848:0.011738:0.013143:0.005792:0.010314:0.007031:0.006523:0.005792:0.013143:0.012450:0.006523:0.007025:0.003848:0.007466:0.007043:0.005713:0.012508:0.013123:0.011699:0.003848:0.005715:0.012508:0.013181:0.007033:0.006042:0.012604:0.005792:0.007025:0.013123:0.012604:0.006523:0.011738:0.007029:0.003848:0.012604:0.015990:0.006388:0.007043:0.013143:0.011738:0.013181:0.005330
high-risk  patients.  Additional primary tu-:@0.523643:0.441484:0.914568:0.441484:0.914568:0.425729:0.523643:0.425729:0.011738:0.003848:0.012950:0.011738:0.006388:0.005792:0.003848:0.007466:0.009660:0.005330:0.006281:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.005330:0.005330:0.006281:0.014239:0.013181:0.013181:0.003848:0.006523:0.003848:0.012604:0.011738:0.013143:0.003848:0.011622:0.013123:0.005792:0.003848:0.018049:0.013143:0.005792:0.010314:0.011622:0.006523:0.011699:0.006388
mours can develop in the urothelium :@0.523643:0.457928:0.919878:0.457928:0.919878:0.442172:0.523643:0.442172:0.018049:0.012604:0.011699:0.005792:0.007466:0.014990:0.012450:0.013143:0.011738:0.014990:0.013181:0.012508:0.010660:0.012508:0.003848:0.012604:0.013123:0.014990:0.003848:0.011738:0.014990:0.006523:0.011738:0.012508:0.014990:0.011699:0.005711:0.012604:0.006523:0.011738:0.012508:0.003848:0.003848:0.011699:0.018049:0.005330
anywhere  along  the  genito-urinary  tract. :@0.523643:0.474372:0.919892:0.474372:0.919892:0.458616:0.523643:0.458616:0.013143:0.011738:0.010314:0.015990:0.011738:0.012508:0.005711:0.012508:0.005330:0.003067:0.013143:0.003848:0.012604:0.011738:0.012950:0.005330:0.003065:0.006523:0.011738:0.012508:0.005330:0.003063:0.012950:0.012508:0.011738:0.003848:0.006523:0.012604:0.006388:0.011688:0.005792:0.003848:0.011738:0.013143:0.005792:0.010314:0.005330:0.003067:0.006523:0.005792:0.013143:0.012450:0.006523:0.005330:0.005330
Subsequent surveillance should include :@0.523643:0.490816:0.919882:0.490816:0.919882:0.475060:0.523643:0.475060:0.009583:0.011699:0.013123:0.007466:0.012508:0.013123:0.011699:0.012508:0.011738:0.006523:0.013874:0.007466:0.011699:0.005792:0.010660:0.012508:0.003848:0.003848:0.003848:0.013143:0.011738:0.012450:0.012508:0.013874:0.007466:0.011738:0.012604:0.011699:0.003848:0.013181:0.013874:0.003848:0.011738:0.012450:0.003848:0.011699:0.013181:0.012508:0.005330
a careful programme of cystoscopy and :@0.523643:0.507260:0.919888:0.507260:0.919888:0.491504:0.523643:0.491504:0.013143:0.007685:0.012450:0.013143:0.005713:0.012508:0.006042:0.011699:0.003848:0.007687:0.013123:0.005715:0.012604:0.012950:0.005792:0.013143:0.018049:0.018049:0.012508:0.007680:0.012604:0.006042:0.007680:0.012450:0.010314:0.007466:0.006523:0.012604:0.007466:0.012450:0.012604:0.013123:0.010314:0.007683:0.013143:0.011738:0.013181:0.005330
urine cytology.:@0.523643:0.523704:0.661495:0.523704:0.661495:0.507948:0.523643:0.507948:0.011699:0.005792:0.003848:0.011738:0.012508:0.005330:0.012450:0.010314:0.006523:0.012604:0.003848:0.012604:0.012950:0.010314:0.005330
Indications for cystectomy include pro-:@0.541827:0.540148:0.914552:0.540148:0.914552:0.524392:0.541827:0.524392:0.004349:0.011738:0.013181:0.003848:0.012450:0.013143:0.006523:0.003848:0.012604:0.011738:0.007466:0.007774:0.006042:0.012604:0.005792:0.007774:0.012450:0.010314:0.007466:0.006523:0.012508:0.012450:0.006523:0.012604:0.018049:0.010314:0.007774:0.003848:0.011738:0.012450:0.003848:0.011699:0.013181:0.012508:0.007774:0.013123:0.005715:0.012604:0.006388
gression to  high-grade  disease (Tis or  T1) :@0.523643:0.556591:0.919884:0.556591:0.919884:0.540835:0.523643:0.540835:0.012950:0.005709:0.012508:0.007466:0.007466:0.003848:0.012604:0.011738:0.008601:0.006523:0.012604:0.005330:0.003262:0.011738:0.003848:0.012950:0.011738:0.006388:0.012950:0.005792:0.013143:0.013181:0.012508:0.005330:0.003258:0.013181:0.003848:0.007466:0.012508:0.013143:0.007480:0.012508:0.008601:0.007100:0.008786:0.003848:0.007466:0.008601:0.012604:0.005792:0.005330:0.003258:0.008197:0.010660:0.007100:0.005330
or  multiple tumours  with  frequent  recur-:@0.523643:0.573035:0.914564:0.573035:0.914564:0.557279:0.523643:0.557279:0.012604:0.005792:0.005330:0.005213:0.018049:0.011699:0.003848:0.006523:0.003848:0.013123:0.003848:0.012508:0.010564:0.006523:0.011699:0.018049:0.012604:0.011699:0.005792:0.007466:0.005330:0.005211:0.015990:0.003848:0.006523:0.011738:0.005330:0.005220:0.006042:0.005713:0.012508:0.013123:0.011699:0.012508:0.011738:0.006523:0.005330:0.005213:0.005711:0.012508:0.012450:0.011699:0.005792:0.006388
rences within a short period of time, de-:@0.523643:0.589479:0.914550:0.589479:0.914550:0.573723:0.523643:0.573723:0.005713:0.012508:0.011738:0.012450:0.012508:0.007466:0.008505:0.015990:0.003848:0.006523:0.011738:0.003848:0.011738:0.008505:0.013143:0.008505:0.007466:0.011738:0.012604:0.005792:0.006523:0.008505:0.013123:0.012508:0.005792:0.003848:0.012604:0.013181:0.008505:0.012604:0.006042:0.008505:0.006523:0.003848:0.018049:0.012508:0.005330:0.008505:0.013181:0.012508:0.006388
spite treatment or complications such as :@0.523643:0.605923:0.919894:0.605923:0.919894:0.590167:0.523643:0.590167:0.007466:0.013123:0.003848:0.006523:0.012508:0.008043:0.006523:0.005711:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.008032:0.012604:0.005792:0.008024:0.012450:0.012604:0.018049:0.013123:0.003848:0.003848:0.012450:0.013143:0.006523:0.003848:0.012604:0.011738:0.007466:0.008043:0.007466:0.011699:0.012450:0.011738:0.008032:0.013143:0.007466:0.005330
bleeding with anaemia and any muscle-:@0.523643:0.622367:0.914569:0.622367:0.914569:0.606611:0.523643:0.606611:0.013123:0.003848:0.012508:0.012508:0.013181:0.003848:0.011738:0.012950:0.007582:0.015990:0.003848:0.006523:0.011738:0.007570:0.013143:0.011738:0.013143:0.012508:0.018049:0.003848:0.013143:0.007582:0.013143:0.011738:0.013181:0.007572:0.013143:0.011738:0.010314:0.007582:0.018049:0.011699:0.007466:0.012450:0.003848:0.012508:0.006388
invasive (T2) disease.:@0.523643:0.638811:0.716683:0.638811:0.716683:0.623055:0.523643:0.623055:0.003848:0.011738:0.010660:0.013143:0.007466:0.003848:0.010660:0.012508:0.005330:0.007100:0.008197:0.010660:0.007100:0.005330:0.013181:0.003848:0.007466:0.012508:0.013143:0.007466:0.012508:0.005330
Muscle-invasive disease:@0.523636:0.672004:0.776353:0.672004:0.776353:0.653983:0.523636:0.653983:0.019242:0.012828:0.009407:0.013683:0.005131:0.013683:0.008980:0.005131:0.012828:0.011973:0.014111:0.009407:0.005131:0.011973:0.013683:0.005987:0.014111:0.005131:0.009407:0.013683:0.014111:0.009407:0.013683
Radical  cystectomy with a urinary di-:@0.523636:0.689594:0.914540:0.689594:0.914540:0.673838:0.523636:0.673838:0.011680:0.013143:0.013181:0.003848:0.012450:0.013143:0.003848:0.005330:0.009365:0.012450:0.010314:0.007466:0.006523:0.012508:0.012450:0.006523:0.012604:0.018049:0.010314:0.014682:0.015990:0.003848:0.006523:0.011738:0.014682:0.013143:0.014682:0.011699:0.005792:0.003848:0.011738:0.013143:0.005792:0.010314:0.014682:0.013181:0.003848:0.006388
version is the  mainstay of  treatment  for :@0.523636:0.706038:0.919889:0.706038:0.919889:0.690282:0.523636:0.690282:0.010660:0.012508:0.005792:0.007466:0.003848:0.012604:0.011738:0.010622:0.003848:0.007466:0.010622:0.006523:0.011738:0.012508:0.005330:0.005278:0.018049:0.013143:0.003848:0.011738:0.007466:0.006523:0.013143:0.010314:0.010622:0.012604:0.006042:0.005330:0.005280:0.006523:0.005711:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.005330:0.005276:0.006042:0.012604:0.005792:0.005330
muscle-invasive  bladder cancer.  Radical :@0.523636:0.722482:0.919868:0.722482:0.919868:0.706726:0.523636:0.706726:0.018049:0.011699:0.007466:0.012450:0.003848:0.012508:0.006388:0.003848:0.011738:0.010660:0.013143:0.007466:0.003848:0.010660:0.012508:0.005330:0.003535:0.013123:0.003848:0.013143:0.013181:0.013181:0.012508:0.005792:0.008852:0.012450:0.013143:0.011738:0.012450:0.012508:0.004376:0.005330:0.005330:0.003512:0.011680:0.013143:0.013181:0.003848:0.012450:0.013143:0.003848:0.005330
cystectomy  entails removal of  the  blad-:@0.523636:0.738926:0.914540:0.738926:0.914540:0.723170:0.523636:0.723170:0.012450:0.010314:0.007466:0.006523:0.012508:0.012450:0.006523:0.012604:0.018049:0.010314:0.005330:0.004068:0.012508:0.011738:0.006523:0.013143:0.003848:0.003848:0.007466:0.009410:0.005711:0.012508:0.018049:0.012604:0.010660:0.013143:0.003848:0.009410:0.012604:0.006042:0.005330:0.004066:0.006523:0.011738:0.012508:0.005330:0.004064:0.013123:0.003848:0.013143:0.013181:0.006388
der, adjacent organs, and regional lymph :@0.523636:0.755370:0.919887:0.755370:0.919887:0.739614:0.523636:0.739614:0.013181:0.012508:0.003768:0.005330:0.005800:0.013143:0.013181:0.003906:0.013143:0.012450:0.012508:0.011738:0.006523:0.005798:0.012604:0.005807:0.012950:0.013143:0.011738:0.007466:0.005330:0.005800:0.013143:0.011738:0.013181:0.005811:0.005713:0.012508:0.012950:0.003848:0.012604:0.011738:0.013143:0.003848:0.005811:0.003848:0.010314:0.018049:0.013123:0.011738:0.005330
nodes.:@0.523636:0.771813:0.586462:0.771813:0.586462:0.756058:0.523636:0.756058:0.011738:0.012604:0.013181:0.012508:0.007466:0.005330
Neoadjuvant  chemotherapy  has been :@0.541820:0.788257:0.919889:0.788257:0.919889:0.772501:0.541820:0.772501:0.014239:0.012508:0.012604:0.013143:0.013181:0.003906:0.011699:0.010660:0.013143:0.011738:0.006523:0.005330:0.003562:0.012450:0.011738:0.012508:0.018049:0.012604:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.005330:0.003552:0.011738:0.013143:0.007466:0.008909:0.013123:0.012508:0.012508:0.011738:0.005330
shown in randomised clinical trials to re-:@0.523636:0.804701:0.914524:0.804701:0.914524:0.788945:0.523636:0.788945:0.007466:0.011738:0.012604:0.015990:0.011738:0.009121:0.003848:0.011738:0.009121:0.005792:0.013143:0.011738:0.013181:0.012604:0.018049:0.003848:0.007466:0.012508:0.013181:0.009121:0.012450:0.003848:0.003848:0.011738:0.003848:0.012450:0.013143:0.003848:0.009121:0.006523:0.005792:0.003848:0.013143:0.003848:0.007466:0.009121:0.006523:0.012604:0.009121:0.005713:0.012508:0.006388
sult in a survival advantage for  patients :@0.523636:0.821145:0.919864:0.821145:0.919864:0.805389:0.523636:0.805389:0.007466:0.011699:0.003848:0.006523:0.009871:0.003848:0.011738:0.009871:0.013143:0.009871:0.007466:0.011699:0.005792:0.010660:0.003848:0.010660:0.013143:0.003848:0.009871:0.013143:0.013181:0.010660:0.013143:0.011738:0.006523:0.013143:0.012950:0.012508:0.009871:0.006042:0.012604:0.005792:0.005330:0.004530:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.005330
with muscle-invasive bladder  cancer :@0.523636:0.837589:0.919875:0.837589:0.919875:0.821833:0.523636:0.821833:0.015990:0.003848:0.006523:0.011738:0.021224:0.018049:0.011699:0.007466:0.012450:0.003848:0.012508:0.006388:0.003848:0.011738:0.010660:0.013143:0.007466:0.003848:0.010660:0.012508:0.021224:0.013123:0.003848:0.013143:0.013181:0.013193:0.012508:0.005792:0.005330:0.015883:0.012450:0.013143:0.011738:0.012450:0.012508:0.005792:0.005330
who receive such chemotherapy prior to :@0.523636:0.854033:0.919877:0.854033:0.919877:0.838277:0.523636:0.838277:0.015990:0.011738:0.012604:0.007254:0.005713:0.012508:0.012450:0.012508:0.003848:0.010660:0.012508:0.007254:0.007466:0.011699:0.012450:0.011738:0.007254:0.012450:0.011738:0.012508:0.018049:0.012604:0.006523:0.011738:0.012492:0.005792:0.013143:0.013123:0.010314:0.007254:0.013123:0.005792:0.003848:0.012604:0.005792:0.007254:0.006523:0.012604:0.005330
undergoing  cystectomy,  and should  be :@0.523636:0.870477:0.919870:0.870477:0.919870:0.854721:0.523636:0.854721:0.011699:0.011738:0.013181:0.012508:0.005792:0.012950:0.012604:0.003848:0.011738:0.012950:0.005330:0.005448:0.012450:0.010314:0.007466:0.006523:0.012508:0.012450:0.006523:0.012604:0.018049:0.010314:0.005330:0.005330:0.005448:0.013143:0.011738:0.013181:0.010795:0.007466:0.011738:0.012604:0.011699:0.003848:0.013181:0.005330:0.005455:0.013123:0.012508:0.005330
considered for all  eligible  patients. Cispl-:@0.523636:0.886920:0.914545:0.886920:0.914545:0.871165:0.523636:0.871165:0.012450:0.012604:0.011738:0.007466:0.003848:0.013181:0.012508:0.005711:0.012508:0.013181:0.008678:0.006042:0.012604:0.005782:0.008678:0.013143:0.003848:0.003848:0.005330:0.003362:0.012508:0.003848:0.003848:0.012950:0.003848:0.013123:0.003848:0.012508:0.005330:0.003362:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.005330:0.008678:0.015644:0.003848:0.007466:0.013123:0.003873:0.006388
atin-based chemotherapy (see section on :@0.523636:0.903364:0.919885:0.903364:0.919885:0.887608:0.523636:0.887608:0.013143:0.006523:0.003848:0.011738:0.006388:0.013123:0.013143:0.007466:0.012508:0.013181:0.004580:0.012450:0.011738:0.012508:0.018049:0.012604:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.004570:0.007100:0.007466:0.012508:0.012508:0.004580:0.007466:0.012508:0.012450:0.006523:0.003848:0.012604:0.011738:0.004580:0.012604:0.011738:0.005330
metastatic disease) is the standard in this :@0.523636:0.919808:0.919870:0.919808:0.919870:0.904052:0.523636:0.904052:0.018049:0.012508:0.006523:0.013143:0.007466:0.006523:0.013143:0.006523:0.003848:0.012450:0.007033:0.013181:0.003848:0.007466:0.012508:0.013143:0.007466:0.012508:0.007100:0.007043:0.003848:0.007466:0.007043:0.006523:0.011738:0.012508:0.007027:0.007466:0.006523:0.013143:0.011738:0.013181:0.013143:0.005677:0.013181:0.007033:0.003848:0.011738:0.007033:0.006523:0.011738:0.003848:0.007466:0.005330
setting.:@0.523636:0.936252:0.590522:0.936252:0.590522:0.920496:0.523636:0.920496:0.007466:0.012508:0.006523:0.006523:0.003848:0.011738:0.012950:0.005330
11:@0.590514:0.930625:0.602944:0.930625:0.602944:0.921439:0.590514:0.921439:0.006215:0.006215